San Francisco, CA, United States of America

Isabelle Nadeau

This inventor holds 3 USPTO granted patents. Top assignees: Geron Corporation, Asterias Biotherapeutics, Inc.. Active years: 2009-2017.


% Patents Active = 33.3

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2009-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Isabelle Nadeau

Introduction

Isabelle Nadeau is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of protocols for creating hepatocytes from embryonic stem cells. With a total of 3 patents, her work has the potential to impact various commercial applications in medicine.

Latest Patents

One of her latest patents focuses on protocols for making hepatocytes from embryonic stem cells. This disclosure presents a newly developed strategy for differentiating pluripotent stem cells into cells of the hepatocyte lineage. The protocols involve a multi-step process where cells are first differentiated into early germ layer cells, then into hepatocyte precursors, and finally into mature cells. The resulting cells exhibit morphological features and phenotypic markers characteristic of human adult hepatocytes. Additionally, they demonstrate evidence of cytochrome P450 enzyme activity, validating their utility for commercial applications such as drug screening and the manufacture of medicaments and medical devices for clinical therapy.

Career Highlights

Throughout her career, Isabelle has worked with notable companies in the biotechnology sector, including Geron Corporation and Asterias Biotherapeutics, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in stem cell technology.

Collaborations

Isabelle has collaborated with several professionals in her field, including Ramkumar Mandalam and Saadia Faouzi. These collaborations have further enhanced her research and innovation efforts.

Conclusion

Isabelle Nadeau's work in developing protocols for hepatocyte differentiation from embryonic stem cells showcases her innovative spirit and dedication to advancing medical science. Her contributions are poised to have a lasting impact on drug development and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…